SMLR — Semler Scientific Balance Sheet
0.000.00%
- $351.00m
- $433.50m
- $56.29m
- 55
- 60
- 44
- 53
Annual balance sheet for Semler Scientific, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-Q | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 22.1 | 37.3 | 43.1 | 57.2 | 14.9 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2.81 | 3.62 | 3.88 | 6.13 | 4.38 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 26.6 | 45.5 | 48.9 | 65.9 | 22.7 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.2 | 2.35 | 3.38 | 3.15 | 1.98 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 34.6 | 50.7 | 62.7 | 78.1 | 240 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.51 | 4.88 | 6.86 | 6.2 | 6.31 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 4.85 | 5.13 | 7.02 | 6.27 | 9.08 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 29.8 | 45.5 | 55.7 | 71.8 | 231 |
| Total Liabilities & Shareholders' Equity | 34.6 | 50.7 | 62.7 | 78.1 | 240 |
| Total Common Shares Outstanding |